Clinical Trial Update: A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial is comparing RO7198457 to watchful waiting in ctDNA-positive, resected high-risk Stage II and Stage III colorectal cancer. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• RO7198457

Snippet

Sponsor: BioNTech SE | Conditions: Colorectal Cancer Stage II, Colorectal Cancer Stage III | Phase 2 | Status: RECRUITING